Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-25

FDA Approved: TRIENTINE HYDROCHLORIDE — Original Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved Endo USA, Inc.'s original application for trientine hydrochloride, a copper chelator indicated for Wilson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIENTINE HYDROCHLORIDE (Trientine hydrochloride)

Snippet

ORIG AP for TRIENTINE HYDROCHLORIDE (TRIENTINE HYDROCHLORIDE)